Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Large B Cell Lymphoma，DLBCL”

1,310 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,310 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06552572
What this trial is testing

Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Samsung Medical Center 30
Testing effectiveness (Phase 2)Ended earlyNCT02378038
What this trial is testing

PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

Who this might be right for
Richter's Transformation
Sierra Oncology LLC - a GSK company 5
Large-scale testing (Phase 3)Study completedNCT04182204
What this trial is testing

Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche 270
Testing effectiveness (Phase 2)Looking for participantsNCT06764017
What this trial is testing

CHiR Therapy for Elderly DLBCL Intolerant to Chemo

Who this might be right for
Diffuse Large B-Cell Lymphoma
First Affiliated Hospital of Ningbo University 30
Testing effectiveness (Phase 2)Study completedNCT04282018
What this trial is testing

Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaFollicular Lymphoma+4 more
BeiGene 97
Testing effectiveness (Phase 2)Looking for participantsNCT06589089
What this trial is testing

Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 18
Large-scale testing (Phase 3)Active Not RecruitingNCT04833114
What this trial is testing

Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Relapsed Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
GWT-TUD GmbH 306
Not applicableStudy completedNCT07134504
What this trial is testing

Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.

Who this might be right for
Prostate Cancer
Instituto Mexicano del Seguro Social 1
Large-scale testing (Phase 3)UnknownNCT02777736
What this trial is testing

CNS Prophylaxis in Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Czech Lymphoma Study Group 500
Testing effectiveness (Phase 2)Ended earlyNCT02592876
What this trial is testing

Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma, B-cellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular, Grade 3b+1 more
Seagen Inc. 81
Early research (Phase 1)Active Not RecruitingNCT04526834
What this trial is testing

Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaPeripheral T Cell LymphomaExtranodal NK/T-cell Lymphoma+2 more
Tessa Therapeutics 21
Very early researchStudy completedNCT01760226
What this trial is testing

Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies

Who this might be right for
Diffuse Large B Cell LymphomaPost Transplant Lymphoproliferative DisorderPrimary Mediastinal (Thymic) Large B-cell Lymphoma
Baylor College of Medicine 4
Testing effectiveness (Phase 2)Ended earlyNCT05720052
What this trial is testing

MS-553 in Patients With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Relapsed or Refractory B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+4 more
MingSight Pharmaceuticals, Inc 8
Early research (Phase 1)Looking for participantsNCT05432635
What this trial is testing

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaDiffuse Large B-Cell LymphomaMantle Cell Lymphoma+5 more
City of Hope Medical Center 15
Not applicableNot Yet RecruitingNCT06652152
What this trial is testing

Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)Double Expressor Lymphoma
Ruijin Hospital 400
Large-scale testing (Phase 3)Study completedNCT00491491
What this trial is testing

Zevalin-beam for Aggressive Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Sheba Medical Center 60
Testing effectiveness (Phase 2)Ended earlyNCT02420210
What this trial is testing

Bendamustine, Obinutuzumab, and Dexamethasone in Older Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
University of Chicago 2
Testing effectiveness (Phase 2)Looking for participantsNCT07254754
What this trial is testing

Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma

Who this might be right for
DIFFUSE LARGE B-CELL LYMPHOMA
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 45
Large-scale testing (Phase 3)Active Not RecruitingNCT04824092
What this trial is testing

Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

Who this might be right for
Diffuse Large B-cell Lymphoma
Incyte Corporation 899
Early research (Phase 1)Study completedNCT03610061
What this trial is testing

A Trial of Radiotherapy and Durvalumab in DLBCL and FL

Who this might be right for
Diffuse Large B Cell LymphomaFollicular Lymphoma
Austin Health 34
Load More Results